Physician

Mark F Berntsen, MD

According to 2025 Medicare claims, Mark Berntsen, MD (NPI: 1730166687) practices internal medicine in the Greeley, CO market, with the plurality of this provider's patient population coming from Weld, CO. This provider's primary affiliated billing organization is POUDRE VALLEY MEDICAL GROUP, LLC (NPI: 1366763260; TIN: 800348943) and primary practice location at 80634-5474. Berntsen is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Banner Network Colorado, LLC (ACO ID: A4768), and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Berntsen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 820 traditional Medicare patients, billed 2,769 HCPCS/CPT codes, and received $114,466 in Medicare payments. The top billing code was 90662 (Influenza vaccine split virus, preservative free). Part D data shows 25,805 prescription claims across 1,711 beneficiaries totaling $2,368,917 in drug costs, led by Eliquis (Apixaban). DME data shows 1,804 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $174,992 to $114,466. In contrast, Part D prescription costs have risen steadily, from $1,378,059 to $2,368,917. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $167,391 and ending at $134,076.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,263	9,523	$174,992
2016	1,258	10,743	$219,791
2017	1,324	9,319	$217,656
2018	1,379	7,518	$268,512
2019	1,088	6,779	$190,790
2020	914	2,749	$174,859
2021	1,004	2,828	$214,345
2022	947	2,718	$120,496
2023	864	2,747	$115,355
2024	820	2,769	$114,466

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,424	28,222	$1,378,059
2016	1,548	27,129	$1,356,741
2017	1,663	28,277	$1,577,629
2018	1,678	26,365	$1,718,347
2019	1,667	24,825	$1,723,813
2020	1,636	24,811	$1,746,450
2021	1,753	25,069	$2,040,364
2022	1,780	25,157	$2,287,160
2023	1,697	25,391	$2,804,945
2024	1,711	25,805	$2,368,917

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	562	2,460	$156,438
2016	498	2,170	$86,954
2017	441	1,831	$54,821
2018	540	1,925	$59,556
2019	475	1,667	$52,979
2020	427	1,672	$72,427
2021	398	1,595	$70,935
2022	393	1,523	$65,977
2023	398	1,773	$95,090
2024	448	1,804	$100,494

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90662	Influenza vaccine split virus, preservative free	107	108	$81
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	548	548	$44
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	528	828	$36
G0008	Administration of influenza virus vaccine	113	114	$33
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	503	685	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	326	21,678	$423,861
Jardiance	Empagliflozin	201	14,864	$295,691
Ozempic	Semaglutide	150	7,948	$253,527
Trulicity	Dulaglutide	71	3,638	$125,227
Januvia	Sitagliptin Phosphate	84	6,461	$118,429

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	14	53	$23,517
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	47	323	$23,124
A7031	Face mask interface, replacement for full face mask, each	N	27	79	$7,253
A7030	Full face mask used with positive airway pressure device, each	N	28	79	$6,620
A4409	Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each	N	N/R	40	$4,263

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Mark F. Berntsen, MD?

Tedicare shows public-source Medicare data for Mark F. Berntsen, MD (NPI 1730166687), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark F. Berntsen, MD have ACO affiliation data?

Mark F. Berntsen, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Banner Network Colorado, LLC (MSSP, ACO ID A4768), and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Mark F. Berntsen, MD?

Mark F. Berntsen, MD is linked to POUDRE VALLEY MEDICAL GROUP, LLC (billing NPI 1366763260) in the available physician profile data.

Does Mark F. Berntsen, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.